What is the classification of natalizumab? Understanding its class and function
•
2 min read
Natalizumab, an immunosuppressant, was temporarily withdrawn from the market in 2005 due to safety concerns regarding a rare brain infection, before being re-approved with a restricted program in 2006. Its classification is complex, primarily as a selective adhesion molecule inhibitor and a monoclonal antibody.
